BTG plc

Company Information

Address:

5 Fleet Place
London
EC4M 7RD

Tel:

+44 (0)20 7575 0000

Fax:

+44 (0)20 7575 0010

E-Mail:

info@btgplc.com

Secretary:

Paul Mussenden

Registrar:

Company Overview

BTG is a world leader in the commercialisation of novel technologies, operating from offices in Europe, North America and Japan. Through a combination of science and technology, patent and legal expertise and business know-how BTG has brought to market such devices as the hovercraft, the commercial safety needle, magnetic resonance imaging (MRI) and interferons (proteins with an ability to prevent viruses replicating in the body). In the week beginning 11 July, subsidiary Provensis received approval from the US Food and Drug Administration (FDA) to resume clinical development of VarisolveĀ®, which is being developed as a massively important microfoam treatment for varicose veins.

Annual Reports

Description Report Date Published
Annual Report 201331-03-201317-05-2013
Annual Report 201231-03-201218-05-2012
Annual Report 201131-03-201124-05-2011
Annual Report 201031-03-201020-05-2010
Annual Report 200931-03-200913-05-2009
Annual Report 200831-03-200816-05-2008
Annual Report 200731-03-200723-05-2007
Annual Report 200631-03-200624-05-2006
Annual Report 200531-03-200525-05-2005
Annual Report 200431-03-200426-05-2004
Annual Report 200331-03-200329-05-2003
Annual Report 200231-03-200230-05-2002

Interim Reports

Description Report Date Published
Interim Report 201330-09-201311-11-2013
Interim Report 201230-09-201207-11-2012
Interim Report 201130-09-201116-11-2011
Interim Report 201030-09-201003-11-2010
Interim Report 200930-09-200904-11-2009
Interim Report 200830-09-200811-11-2008
Interim Report 200730-09-200706-11-2007
Interim Report 200630-09-200608-11-2006
Interim Report 200530-09-200509-11-2005
Interim Report 200430-09-200411-11-2004
Interim Report 200330-09-200303-12-2003
Interim Report 200230-09-200203-12-2002

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #